The Global Strategy Lab was designated as the WHO Collaborating Centre on Global Governance of Antimicrobial Resistance in 2019.
The WHO Collaborating Centre on Global Governance of Antimicrobial Resistance at GSL uses rigorous and innovative research support the World Health Organization in assessing and addressing the growing global health and development threat of antimicrobial resistance (AMR).
Now in its second mandate period (2023-2027), the WHOCC at GSL is focussed on providing policy research support to the WHO in the following areas:
- Support for policy analysis and research on multisectoral governance instruments, and accountability and financing mechanisms towards addressing AMR through a multi-sectoral One Health approach.
- Support for conducting targeted research, evidence reviews, data analysis, policy analysis to support the implementation of the People-centered framework of AMR interventions in the human health sector.
- Support for delivering technical assistance for the development, governance, financing, effective implementation, and evaluation of multisectoral AMR national action plans (NAPs) at the country level.
Inaugural Mandate (2019-2023)
During its inaugural mandate, the WHOCC at GSL worked closely with institutional and academic partners around the world to improve global political mobilization and accountability towards the WHO’s Global Action Plan on AMR and improving the scientific evidence base on national and global responses to AMR.
About WHOCC
WHO collaborating centres are institutions designated by the WHO Director-General to provide strategic support through:
- Implementing WHO’s mandated work and programme objectives
- Developing and strengthening institutional capacity in countries and regions.
Previous